1. Eylea Listed for Branch Retinal Vein Occlusion

    mivision | 05 December 2016

    Australians diagnosed with visual impairment due to macular oedema secondary to branch retinal vein occlusion (BRVO) have a new and promising treatment option following inclusion of Eylea (aflibercept) on the Pharmaceutical Benefits Scheme (PBS) from 1... Read More

  2. ProVision Partners with 1stAvailable Health...

    mivision | 28 November 2016

    ProVision has partnered with 1stAvailable, the Australian online health portal, to manage online optical appointment bookings. The online platform was successfully piloted by 20 ProVision practices from August through to November 2016, and the group has now... Read More

  3. Survey to Identify Needs for Macular Disease Care

    mivision | 28 November 2016

    Macular Disease Foundation Australia will soon commence national online research with all eye care professionals to determine how the Foundation can better meet their needs in delivering patient care. According to the Foundation, these needs may include the... Read More

  4. Dr. Andrew White Promoted to Clinical Associate...

    mivision | 28 November 2016

    Ophthalmologist Dr. Andrew White has been promoted to the role of Clinical Associate Professor at the University of Sydney. Clin A/Prof White has dedicated his career to glaucoma and assists the NSW Government on health policy. An internationally recognised... Read More

  5. Oculo to Integrate with Global Transcription...

    mivision | 28 November 2016

    Oculo and Sydney-based online medical typing service Global Transcription Services (GTS) will link their software services in an agreement “designed to reduce practice costs and enhance operational efficiency”. Ophthalmologists and other medical... Read More

  6. ProVision Learns ‘Five Rs’ for Retaining...

    mivision | 28 November 2016

    To win the battle for relevance, optometrists must “recalibrate, reengineer, reframe, re-imagine and re-position,” according to social researcher Michael McQueen. Mr. McQueen was speaking to 120 ProVision optometrists and practice staff at a... Read More

  7. OA Comments on Medicare

    mivision | 25 November 2016

    Bulk billing rates for optoetry services have reduced by just 3 per cent since Medicare changes were implemented almost one year ago, according to Genevieve Quilty, CEO of Optometry Australia. On 1 January 2015 the cap on fees optometrists can charge under... Read More

  8. Ozurdex PBS Listed for Diabetic Macular Edema

    mivision | 25 November 2016

    Ozurdex (dexamethasone 700mcg), a new, sustained-release eye implant, has been listed on the Pharmaceutical Benefits Scheme (PBS). The treatment is indicated for patients with visual impairment due to diabetic macular oedema (DME) who have had cataract... Read More

  9. AMD Eye Scan: Is it enough?

    mivision | 25 November 2016

    Macular Disease Foundation Australia welcomed the news that Medicare would provide a rebate for the use of an ocular coherence tomography (OCT) scan for the initial diagnosis of 'wet' age-related macular degeneration, diabetic macular oedema (DME) and other... Read More

  10. Study Shows Caffeine May Benefit AMD!

    mivision | 25 November 2016

    Embracing the Mediterranean diet, especially through increasing the intake of fruit, may reduce the risk of developing age-related macular degeneration (AMD), by one third. The study, presented at the recent 120th anniversary of the American Academy of... Read More

1 | 2 | 3 | 4 | ... Next> | Last>